$SCHW has released its latest earnings report, revealing enhanced financial performance with an EPS of $1.14, exceeding estimates by $0.04, and a year-over-year revenue growth of 24.75% to reach $5.85B.

$AXP reports Q2 2025 earnings with solid performance: EPS of $4.08 (+17% YoY), revenue at $17.86B (+9% YoY). Yet, potential risks linger with softer T&E spending growth. With robust profitability and financial health indicators, including a 36% ROE and a CCAR stress buffer at 2.5%, the future remains optimistic. 💳✨ New premium card offerings and increased Card Member engagement signal growth opportunities, while challenges persist in the oversaturated premium space. Check details at valueverge.com/AXP.

$PEP has released its Q2 2025 earnings, reporting an EPS of $2.12, surpassing estimates by $0.09. Revenue reached $22.73B, showing a slight year-over-year growth of 1.00%. 📈 However, concerns around potential productivity declines due to a reduced asset footprint may pose risks.

$ABT has released its Q2 2025 earnings, where EPS of $1.26 met expectations while revenue reached $11.14B, reflecting a 7.37% year-over-year increase. Despite a 1.5% decline in diagnostics sales, particularly in COVID testing, other divisions showed resilience with medical devices growing by 12%. Key risks include ongoing headwinds from COVID impacts and geopolitical issues in China. Future opportunities hinge on product advancements, especially in diabetes care and biosimilars. 📊✨ For more details, check valueverge.com/ABT.

$GE reports Q2 2025 earnings with an EPS of $1.66, beating estimates by $0.23, and revenue of $10.15B, up 23.45% YoY. Key stats indicate strong profitability with a 23% margin, but potential risks from macroeconomic dynamics. 📈 Quarterly highlights include 30% service revenue growth and impressive backlog expansion. Future opportunities hinge on strong defense contracts and commercial demand despite slight caution on departure growth. Check details in valueverge.com/GE.

🚨 $NFLX just released their Q2 2025 earnings! EPS at $7.19 beats expectations by $0.10 🎉 and revenue reaches $11.08B (+15.9% Y/Y) 🚀. Key stats reveal a projected annual revenue increase, largely driven by FX and member growth, while operating margins are adjusted to 30%.

$TSM announces its Q2 2025 earnings, with EPS of $2.47, beating expectations by $0.16, and revenue hitting $31.73B, marking a 54.18% year-over-year increase. Key highlights: strong demand for advanced 3nm and 5nm technologies but affected by foreign exchange rates impacting gross margins (58.6%) and profit margins.

$MS has released its Q2 2025 earnings, showcasing solid results with an EPS of $2.13, exceeding estimates by $0.15, and revenues of $16.79B, up 11.81% YOY. Risks include market volatility, but highlights are a strong return on tangible equity of 18.2%.

$ASML has released its Q2 earnings, highlighting a solid EPS of $6.86, exceeding expectations, and total revenue of $8.95 billion, up 31.07% year-over-year. Key risks include macroeconomic uncertainty impacting customer investments and continued tariff discussions. In terms of profitability, gross margins reached 53.7%. Future outlook remains optimistic, with strong demand in AI driving growth. However, customers are cautious regarding CAPEX based on geopolitical tensions. For more details, check valueverge.com/ASML. 📈💰📉

$JNJ announces its Q2 2025 earnings: EPS at $2.77, beating estimates by $0.09, with revenue at $23.74B (+5.77% YoY). Notably, 13 brands reported double-digit growth despite challenges from STELARA's biosimilar competition. 🚀 Key highlights in growth (4.6%) across diverse sectors, especially Innovative Medicine and MedTech. Future prospects look solid, with important product launches ahead. 📈 However, watch for risks related to market competition and increased debt from acquisitions. For more details, check valueverge.com/JNJ.

$C announced their Q2 2025 earnings, reporting an EPS of $1.96, surpassing expectations, with revenues hitting $21.67B, a 8% increase Y/Y. Highlights include a positive operating leverage across 5 businesses and a strong ROTCE of 8.7%. Notably, expenses were tightly controlled despite increased transformation costs.

$BLK has reported its Q2 2025 earnings, showcasing strategic growth in several areas. Key stats reveal an EPS of $12.05, exceeding expectations by $1.23, while revenue reached $5.42B, a 12.86% year-over-year increase, yet slightly below estimates. The firm’s financial health remains robust with an AUM of $12.5 trillion and organic base fee growth of 7% over the past year. 🌟

$WFC has released Q2 2025 earnings, showcasing a robust EPS of $1.54 (beating estimates by $0.14) and revenue of $20.82B, a slight Y/Y increase of 0.64%. Positive indicators include improved profitability and a notably reduced net loan charge-off ratio. However, risks persist, particularly concerning ongoing economic uncertainty.

$JPM has just released its Q2 2025 earnings, reporting an EPS of $5.24 and revenue of $45.7B, beating estimates even with a 10% YoY revenue decline. 📉 Key stats show a ROTCE of 21%, but credit costs have increased due to new lending activity. 🔍

$NKE has reported its Q4 2025 earnings, revealing an EPS of $0.14, beating expectations by $0.02, while revenue of $11.10B shows a significant decline of 11.97% year-over-year. Key financial risks include declining gross margins due to high promotional activities and tariffs impacting supply costs.

$MU has released its Q3 2025 earnings, showcasing significant growth and performance. The company reported an EPS of $1.91, beating expectations by $0.31, alongside revenue of $9.30B—up 36.56% year-over-year, indicating strong financial health.

$ADBE has released its Q2 2025 earnings, highlighting strong performance with an EPS of $5.06, beating expectations, and revenue of $5.87 billion, up 11% Y/Y. 📈 Digital Media revenue grew 12%, driven by user demand for AI-enhanced products, but risks remain regarding market competition and economic conditions.

$LULU has released its Q1 2025 earnings report. Total revenue rose 7% year-over-year to $2.37 billion, beating expectations, while EPS of $2.60 fell slightly short. Key highlights include a 60 basis point increase in gross margin, reflecting strong financial health. Risks such as tariffs and cautious consumer spending may impact future margins 📉. With a robust new product pipeline, strategic store openings, and an expanded market presence in China, lululemon remains focused on long-term growth opportunities🌱. For further insights, check details in valueverge.com/LULU.

$AVGO reports Q2 2025 earnings with a record revenue of $15B, up 20% YoY, and EPS of $1.58, beating estimates. Key stats show strong growth in AI semiconductors 🚀, though non-AI segments are down 5%.

$MRVL has just released its Q1 2026 earnings, with EPS at $0.62 and revenue of $1.90B, marking a remarkable 63% year-over-year growth. Key highlights include strong demand for AI-driven solutions and a significant increase in stock buybacks, totaling $340M this quarter.